COVID-19

Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell

Mass Production Readiness Targeted for 2H 2024Propelling AI Nose Technology Towards Broader Industry Adoption and Advancing the Mission of Digitalizing…

1 year ago

CVRx receives FDA approval for expanded labeling of Barostim

U.S. annual market opportunity increases based on real world adoption and strength of long-term BeAT-HF dataMINNEAPOLIS, Dec. 26, 2023 (GLOBE NEWSWIRE)…

1 year ago

ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing…

1 year ago

ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools

Company Urges Stockholders to Vote “FOR” Value Maximizing Transaction at Upcoming Special MeetingBOULDER, Colo., Dec. 22, 2023 (GLOBE NEWSWIRE) --…

1 year ago

Foothold Technology Launches New Solution to Coordinate Care and Track Outcomes for Social Care Networks

NEW YORK--(BUSINESS WIRE)--Foothold Technology, a leading Behavioral Health and Human Services software provider backed by ASG, unveiled a groundbreaking ecosystem…

1 year ago

Legacy ER & Urgent Care Announces Rapid Testing and Treatment for COVID-19, Flu and RSV Amidst Holiday Season Surge

PLANO, TX / ACCESSWIRE / December 21, 2023 / As families gather for the holiday season, Legacy ER & Urgent…

1 year ago

Pharma-Bio Serv Announces Special Dividend

DORADO, PUERTO RICO / ACCESSWIRE / December 21, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a…

1 year ago

SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools

Combination Builds Scale and Accelerates Path to Profitability, Unlocking Significant Potential Value for SomaLogic Stockholders Madryn’s Concerns are Not Based…

1 year ago

Moderna to Present at the 42nd Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, MA / ACCESSWIRE / December 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), today announced that Jamey Mock, Chief Financial Officer,…

1 year ago

Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X

CHICAGO, IL / ACCESSWIRE / December 20, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

1 year ago